AbbVie Inc., US00287Y1091

AbbVie declares a quarterly dividend as AbbVie stock trades flat at EUR 233.55

Published on 10/04/2026 at 17:40 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

AbbVie stock costs EUR 233.55 in weekend trading on October 4, 2026 versus a Xetra close of EUR 233.55. AbbVie declared a USD 1.73 quarterly dividend.

Fotorealistisches Pharma-Forschungslabor mit Petrischalen und Wissenschaftlern in Schutzkleidung
AbbVie Inc. US00287Y1091 fotorealistisches Pharma Forschungslabor mit Petrischalen Wissenschaftlern Immunologie Onkologie Biopharma, Illustration mit AI erstellt.

AbbVie Inc. declared a quarterly cash dividend of USD 1.73 per share on September 10, 2026, payable November 16, 2026, to stockholders of record on October 15, 2026, according to PR Newswire. AbbVie stock trades flat at EUR 233.55 in weekend trading at Lang & Schwarz as of 5:36:52 p.m. CEST on October 4, 2026, unchanged at 0.00 percent versus the EUR 233.55 close at Lang & Schwarz on October 2, 2026.

Weekend trading at Lang & Schwarz

The EUR 233.55 price is unchanged from the EUR 233.55 close at Lang & Schwarz on October 2, 2026. The bid was EUR 233.30 and the ask was EUR 233.80 at 5:36:52 p.m. CEST on October 4, 2026. The further course of weekend trading at Lang & Schwarz until 7:00 p.m. CEST is shown by the continuously updated real-time quote of AbbVie stock.

The last Xetra trading day

Lang & Schwarz recorded a closing price of EUR 233.55 for AbbVie on October 2, 2026. The weekend indication therefore stands at EUR 233.55, or 0.00 percent versus that dated close.

Dividend declaration

AbbVie said its board had declared the USD 1.73 quarterly cash dividend on September 10, 2026. The payment is scheduled for November 16, 2026, and the record date is October 15, 2026. The company said shareholders must be recorded at the close of business on the record date. The announcement was distributed by PR Newswire.

Next Xetra session

The next Xetra session is scheduled for October 5, 2026.

Disclaimer...

en | US00287Y1091 | ABBVIE INC. | boerse | 70226625 | bgmi